相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of Molecular Determinants in iRhoms1 and 2 That Contribute to the Substrate Selectivity of Stimulated ADAM17
Yi Zhao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Analysis of the Conditions That Affect the Selective Processing of Endogenous Notch1 by ADAM10 and ADAM17
Rolake O. Alabi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Members of the Fibroblast Growth Factor Receptor Superfamily Are Proteolytically Cleaved by Two Differently Activated Metalloproteases
Garima Dixit et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
ADAM10 Site-Dependent Biology: Keeping Control of a Pervasive Protease
Francesca Tosetti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
ADAM17-A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer
Christoph Rogmans et al.
CANCERS (2021)
Pharmacological disruption of the Notch transcription factor complex
Rajwinder Lehal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Genomic characterization of five commonly used endometrial cancer cell lines
Eric J. Devor et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
An integrated prediction model of recurrence in endometrial endometrioid cancers
Marina D. Miller et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Meprin β induces activities of A disintegrin and metalloproteinases 9, 10, and 17 by specific prodomain cleavage
Rielana Wichert et al.
FASEB JOURNAL (2019)
ADAM17: An Emerging Therapeutic Target for Lung Cancer
Mohamed Saad et al.
CANCERS (2019)
Investigational PI3K/AKT/mTOR inhibitors in development for endometrial cancer
Fabio Barra et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
Modeling Endometrial Cancer: Past, Present, and Future
Tom Van Nyen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Pathology of cancers of the female genital tract including molecular pathology
Jaime Prat et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2018)
Mismatch repair deficiency and aberrations in the Notch and Hedgehog pathways are of prognostic value in patients with endometrial cancer
Genovefa Polychronidou et al.
PLOS ONE (2018)
FGFR2 Promotes Gastric Cancer Progression by Inhibiting the Expression of Thrombospondin4 via PI3K-Akt-Mtor Pathway
Tingting Huang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study
Yvette W. Jeske et al.
GYNECOLOGIC ONCOLOGY (2017)
Dynamics of cell transformation in culture and its significance for tumor development in animals
Harry Rubin
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Fibroblast Growth Factor 7 Regulates Proliferation and Decidualization of Human Endometrial Stromal Cells via ERK and JNK Pathway in an Autocrine Manner
Wen-Jie Zhou et al.
REPRODUCTIVE SCIENCES (2017)
Targeting fibroblast growth factor pathways in endometrial cancer
Boris Winterhoff et al.
CURRENT PROBLEMS IN CANCER (2017)
Human Endometrial Fibroblasts Derived from Mesenchymal Progenitors Inherit Progesterone Resistance and Acquire an Inflammatory Phenotype in the Endometrial Niche in Endometriosis
Fatima Barragan et al.
BIOLOGY OF REPRODUCTION (2016)
An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growth
Lakmali Atapattu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
The breast cancer susceptibility FGFR2 provides an alternate mode of HER2 activation
W Wei et al.
ONCOGENE (2015)
RNA-seq analysis reveals significant effects of EGFR signalling on the secretome of mesenchymal stem cells
Antonella De Luca et al.
Oncotarget (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
Targeting molecular pathways in endometrial cancer: A focus on the FGFR pathway
Paula S. Lee et al.
CANCER TREATMENT REVIEWS (2014)
Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
Jiezhong Chen et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Collection of a lifetime: A practical approach to developing a longitudinal collection of women's healthcare biological samples
Mark K. Santillan et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2014)
miR-451 Deficiency Is Associated with Altered Endometrial Fibrinogen Alpha Chain Expression and Reduced Endometriotic Implant Establishment in an Experimental Mouse Model
Warren B. Nothnick et al.
PLOS ONE (2014)
Constitutive and ligand-induced EGFR signalling triggers distinct and mutually exclusive downstream signalling networks
Sharmistha Chakraborty et al.
NATURE COMMUNICATIONS (2014)
Notch- EGFR/ HER2bidirectionalcrosstalkinbreastcancer
Andrew T. Baker et al.
FRONTIERS IN ONCOLOGY (2014)
Crosstalk of oncogenic signaling pathways during epithelial-mesenchymal transition
Stephan Lindsey et al.
FRONTIERS IN ONCOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
The N550K/H Mutations in FGFR2 Confer Differential Resistance to PD173074, Dovitinib, and Ponatinib ATP-Competitive Inhibitors
Sara A. Byron et al.
NEOPLASIA (2013)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features
Sara A. Byron et al.
PLOS ONE (2012)
High-Throughput Mutation Profiling of Primary and Metastatic Endometrial Cancers Identifies KRAS, FGFR2 and PIK3CA to Be Frequently Mutated
Camilla Krakstad et al.
PLOS ONE (2012)
The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma
Kai Doberstein et al.
CARCINOGENESIS (2011)
Selective repression of Notch pathway target gene transcription
John W. Cave
DEVELOPMENTAL BIOLOGY (2011)
Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
Mitch Dowsett et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
A transforming Src mutant increases the bioavailability of EGFR ligands via stimulation of the cell-surface metalloproteinase ADAM17
T. Maretzky et al.
ONCOGENE (2011)
Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17
Thorsten Maretzky et al.
NATURE COMMUNICATIONS (2011)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
FGFR2 as a molecular target in endometrial cancer
Sara A. Byron et al.
FUTURE ONCOLOGY (2009)
Metalloprotease ADAM10 Is Required for Notch1 Site 2 Cleavage
Geert van Tetering et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Drug-sensitive FGFR2 mutations in endometrial carcinoma
Amit Dutt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes
P. M. Pollock et al.
ONCOGENE (2007)
Pharmacokinetics and pharmacodynamics of DPC 333 ((2R)-2-((3R)-3-amino-3{4-[2-methyl-4-quinolinyl) methoxy] phenyl}-2-oxopyrrolidinyl)-N-hydroxy-4-methylpentanamide)), a potent and selective inhibitor of tumor necrosis factor α-converting enzyme in rodents, dogs, chimpanzees, and humans
Mingxin Qian et al.
DRUG METABOLISM AND DISPOSITION (2007)
Cortactin involvement in the keratinocyte growth factor and fibroblast growth factor 10 promotion of migration and cortical actin assembly in human keratinocytes
Simona Ceccarelli et al.
EXPERIMENTAL CELL RESEARCH (2007)
Keratinocyte growth factor expression and activity in cancer: Implications for use in patients with solid tumors
Paul W. Finch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells
Phillip C. C. Liu et al.
CANCER BIOLOGY & THERAPY (2006)
Preclinical analysis of the analinoquinazoline AG14781 a specific small molecule inhibitor of EGF receptor tyrosine kinase
AG Ellis et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
Adams: Key components in EGFR signalling and development
CP Blobel
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands
U Sahin et al.
JOURNAL OF CELL BIOLOGY (2004)
Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities
OA Ibrahimi et al.
HUMAN MOLECULAR GENETICS (2004)
EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2
YJ Wu et al.
BIOLOGICAL CHEMISTRY (2003)
Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling
LF Jackson et al.
EMBO JOURNAL (2003)
Fibroblast growth factor 7, secreted by breast fibroblasts, is an interleukin-1β-induced paracrine growth factor for human breast cells
C Palmieri et al.
JOURNAL OF ENDOCRINOLOGY (2003)
Tumor necrosis factor-α converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability
SW Sunnarborg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Epidermal growth factor receptor-dependent control of keratinocyte survival and Bcl-xL expression through a MEK-dependent pathway
M Jost et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
